Arcus Biosciences (NYSE:RCUS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Arcus Biosciences Stock (NYSE: RCUS) stock price, news, charts, stock research, profile.

Open	$15.62
Close	-
Volume / Avg.	13.99K / 602.11K
Day Range	$15.42 - $15.75
52 Wk Range	12.95 - 20.48
Market Cap	$1.42B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	42
Short Interest	15.58%
Days to Cover	15.06

Recent News

After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies

Gilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival and objective response rates. New data from the ARC-9 study highlights significant survival benefits in metastatic colorectal cancer.

Vandana Singh

$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Avi Kapoor

Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$15.62
Close	-
Volume / Avg.	13.99K / 602.11K
Day Range	$15.42 - $15.75
52 Wk Range	12.95 - 20.48
Market Cap	$1.42B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	42
Short Interest	15.58%
Days to Cover	15.06

About Arcus Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcus Biosciences (RCUS) stock?

You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.

View our list of the best stock brokerages

Who are Arcus Biosciences (RCUS) competitors?

Other companies in Arcus Biosciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Arcus Biosciences (RCUS) stock?

Arcus Biosciences has a consensus price target of $44.31.

What is the current price for Arcus Biosciences (RCUS)?

The stock price for Arcus Biosciences (NYSE: RCUS) is $15.6 last updated September 24, 2024 at 4:00 PM EDT.

Does Arcus Biosciences (RCUS) pay a dividend?

There are no upcoming dividends for Arcus Biosciences.

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

Arcus Biosciences’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Arcus Biosciences (RCUS) going to split?

There is no upcoming split for Arcus Biosciences.

What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Top Stock Ideas Sent Daily — Join and Gain Your Edge